A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Apitolisib (Primary)
- Indications Breast cancer; Endometrial cancer; Non-Hodgkin's lymphoma; Renal cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Genentech
- 29 Jul 2013 Actual end date changed from Mar 2012 to Jan 2012, as reported by ClinicalTrials.gov.
- 30 Aug 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
- 10 Dec 2011 New trial record